Skip to content

The role of pharmacist for enhancing medication adherence in COPD (Chronic Obstructive Pulmonary Diseases) patients in pakistan

Exploring the pharmacist's intervention for precluding the factors effecting medication adherence in Chronic Obstructive Pulmonary Diseases (COPD) following GOLD (Global Initiative for Chronic Obstructive Lungs diseases) guidelines in Pakistan

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220516054875N1
Enrollment
150
Registered
2022-05-23
Start date
2022-06-01
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease (COPD). Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention group:.

Sponsors

Quaid-i-Azam University , Islamabad
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients only attend the outpatient COPD wards, confirmed diagnosis of COPD by the hospital consultant for at least 1 year Newly diagnosed patients with a forced expiratory volume in 1 s (FEV1) of 30–80% of the predicted normal value Patients that hospital consultant agree that the patient is suitable for entering the trial

Exclusion criteria

Exclusion criteria: Moderate to severe learning difficulties Mobility problems, confusion, disorientation or terminal illness Congestive heart failure or if they are attending a pulmonary rehabilitation programs consulting a pulmonary nurse or clinical pharmacist in the last 6 months

Design outcomes

Primary

MeasureTime frame
The medication adherence by pharmacist intervention will be improved. Timepoint: Before intervention, after 24 weeks of intervention. Method of measurement: Self-structured medication adherence Questionnaire will be filled to check the adherence level.

Secondary

MeasureTime frame
Assessment of patient quality of life by St. George Respiratory Questionnare. Timepoint: Before intervention and after 24 weeks of intervention. Method of measurement: Patients interviews.

Countries

Pakistan

Contacts

Public ContactDr. Amjad Khan

Quaid-i-Azam university, islamabad

amjadkhad@qua.edu.pk+92 51 90644128

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026